Flanking-sequence exponential anchored-polymerase chain reaction amplification: A sensitive and highly specific method for detecting retroviral integrant-host-junction sequences

Cytotherapy

Volumn 10, Issue 5, 2008, Pages 526-539

  Pule, M A ^a   Rousseau, A ^a   Vera, J ^a   Heslop, H E ^a,b,c,d   Brenner, M K ^a,b,c,d   Vanin, E F ^a  

^a CENTER FOR CELL AND GENE THERAPY   (United States)

^b Department of Pediatrics ^*  (United States)

^c HOUSTON METHODIST HOSPITAL   (United States)

^d TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

Gene therapy; Integration site analysis; LAM PCR; Polymerase chain reaction; Retrovirus

Indexed keywords

RETROVIRUS VECTOR;

ARTICLE; CAPILLARY ELECTROPHORESIS; CLONE; COMPUTER PROGRAM; CONTROLLED STUDY; DNA FLANKING REGION; GENE AMPLIFICATION; GENE CASSETTE; HUMAN; HUMAN CELL; NONHUMAN; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROCESS DEVELOPMENT; RESTRICTION MAPPING; RETROVIRUS; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS; VIRAL GENE DELIVERY SYSTEM; VIRUS DNA CELL DNA INTERACTION;

EID: 53249105450     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1080/14653240802192636     Document Type: Article

References (37)

1. Schmidt, M., Zickler, P. Hoffmann, G. et al. (2002) Polyclonal long-term repopulating stem cell clones in a primate model. Blood, 100, pp. 2737-2743.
2. Brenner, MK, Rill, DR Moen, RC et al. (1993) Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet, 341, pp. 85-86.
3. Heslop, HE and Rooney, CM. (1997) Adoptive cellular immunotherapy for EBV lymphoproliferative disease. Immunol Rev, 157, pp. 217-222.
4. Kohn, DB, Hershfield, MS Carbonaro, D. et al. (1998) T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates. Nat Med, 4, pp. 775-780.
5. Hacein-Bey-Abina, S., Le Deist, F Carlier, F. et al. (2002) Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. New Engl J Med, 346, pp. 1185-1193.
6. Schroder, AR, Shinn, P. Chen, H. et al. (2002) HIV-1 integration in the human genome favors active genes and local hotspots. Cell, 110, pp. 521-529.
7. Wu, X., Li, Y., Crise, B. and Burgess, SM. (2003) Transcription start regions in the human genome are favored targets for MLV integration. Science, 300, pp. 1749-1751.
8. Laufs, S., Gentner, B. Nagy, KZ et al. (2003) Retroviral vector integration occurs in preferred genomic targets of human bone marrow-repopulating cells. Blood, 101, pp. 2191-2198.
9. Mitchell, RS, Beitzel, BF Schroder, AR et al. (2004) Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol, 2, p. E234.
10. Donahue, RE, Kessler, SW Bodine, D. et al. (1992) Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J Exp Med, 176, pp. 1125-1135.
11. Hacein-Bey-Abina, S., von Kalle, C. Schmidt, M. et al. (2003) A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. New Engl J Med, 348, pp. 255-256.
12. Hacein-Bey-Abina, S., von Kalle, C. Schmidt, M. et al. (2003) LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science, 302, pp. 415-419.
13. Mueller, PR and Wold, B. (1989) In vivo footprinting of a muscle specific enhancer by ligation mediated PCR. Science, 246, pp. 780-786.
14. Schmidt, M., Hoffmann, G. Wissler, M. et al. (2001) Detection and direct genomic sequencing of multiple rare unknown flanking DNA in highly complex samples. Hum Gene Ther, 12, pp. 743-749.
15. Cosset, FL, Takeuchi, Y. Battini, JL et al. (1995) High-titer packaging cells producing recombinant retroviruses resistant to human serum. J Virol, 69, pp. 7430-7436.
16. Rooney, CM, Smith, CA Ng, CY et al. (1995) Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet, 345, pp. 9-13.
17. Cosset, FL, Takeuchi, Y. Battini, JL et al. (1995) High-titer packaging cells producing recombinant retroviruses resistant to human serum. J Virol, 69, pp. 7430-7436.
18. Pearson, WR and Lipman, DJ. (1988) Improved tools for biological sequence comparison. Proc Natl Acad Sci USA, 85, pp. 2444-2448.
19. Eddy, SR. (2004) What is dynamic programming?. Nat Biotechnol, 22, pp. 909-910.
20. SantaLucia Jr, J., Allawi, HT and Seneviratne, PA. (1996) Improved nearest-neighbor parameters for predicting DNA duplex stability. Biochemistry, 35, pp. 3555-3562.
21. Rossig, C., Bollard, CM Nuchtern, JG et al. (2002) Epstein-Barr virus-specific human T lymphocytes expressing antitumor chimeric T-cell receptors: Potential for improved immunotherapy. Blood, 99, pp. 2009-2016.
22. Swaminathan, N., Mead, DA McMaster, K. et al. (1996) Molecular cloning of the three base restriction endonuclease R.CviJI from eukaryotic Chlorella virus IL-3A. Nucleic Acids Res, 24, pp. 2463-2469.
23. Kuramoto, K., Follman, D. Hematti, P. et al. (2004) The impact of low-dose busulfan on clonal dynamics in nonhuman primates. Blood, 104, pp. 1273-1280.
24. Kuramoto, K., Follmann, DA Hematti, P. et al. (2004) Effect of chronic cytokine therapy on clonal dynamics in nonhuman primates. Blood, 103, pp. 4070-4077.
25. Shi, PA, Angioletti, MD Donahue, RE et al. (2004) In vivo gene marking of rhesus macaque long-term repopulating hematopoietic cells using a VSV-G pseudotyped versus amphotropic oncoretroviral vector. J Gene Med, 6, pp. 367-373.
26. Puskas, LG, Fartmann, B. and Bottka, S. (1994) Restricted PCR: amplification of an individual sequence flanked by a highly repetitive element from total human DNA. Nucleic Acids Res, 22, pp. 3251-3252.
27. Minami, M., Poussin, K., Brechot, C. and Paterlini, P. (1995) A novel PCR technique using Alu-specific primers to identify unknown flanking sequences from the human genome. Genomics, 29, pp. 403-408.
28. Parker, JD, Rabinovitch, PS and Burmer, GC. (1991) Targeted gene walking polymerase chain reaction. Nucleic Acids Res, 19, pp. 3055-3060.
29. Sorensen, AB, Duch, M., Jorgensen, P. and Pedersen, FS. (1993) Amplification and sequence analysis of DNA flanking integrated proviruses by a simple two-step polymerase chain reaction method. J Virol, 67, pp. 7118-7124.
30. Gentner, B., Laufs, S. Nagy, KZ et al. (2003) Rapid detection of retroviral vector integration sites in colony-forming human peripheral blood progenitor cells using PCR with arbitrary primers. Gene Ther, 10, pp. 789-794.
31. Ochman, H., Gerber, AS and Hartl, DL. (1988) Genetic applications of an inverse polymerase chain reaction. Genetics, 120, pp. 621-623.
32. Riley, J., Butler, R. Ogilvie, D. et al. (1990) A novel, rapid method for the isolation of terminal sequences from yeast artificial chromosome (YAC) clones. Nucleic Acids Res, 18, pp. 2887-2890.
33. Arnold, C. and Hodgson, IJ. (1991) Vectorette PCR: A novel approach to genomic walking. PCR Methods Appl, 1, pp. 39-42.
34. Carteau, S., Hoffmann, C. and Bushman, F. (1998) Chromosome structure and human immunodeficiency virus type 1 cDNA integration: Centromeric alphoid repeats are a disfavored target. J Virol, 72, pp. 4005-4014.
35. Devon, RS, Porteous, DJ and Brookes, AJ. (1995) Splinkerettes: Improved vectorettes for greater efficiency in PCR walking. Nucleic Acids Res, 23, pp. 1644-1645.
36. Ivics, Z., Hackett, PB, Plasterk, RH and Izsvak, Z. (1997) Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell, 91, pp. 501-510.
37. Brenner, S., Johnson, M. Bridgham, J. et al. (2000) Gene expression analysis by massively parallel signature sequencing (MPSS) on microbead arrays. Nat Biotechnol, 18, pp. 630-634.